{"disease":{"id":"hepatic-function","name":"hepatic function"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT04014413","title":"Safety and Efficacy of Fecal Microbiota Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03961087","title":"Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT03933891","title":"Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT03654183","title":"Predictive Value of Intraoperative Indocyanine Green Clearance Test After Partially Blood Flow Blocking in Postoperative Liver Reserve","phase":"","overall_status":"UNKNOWN","enrollment_count":170,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05793203","title":"Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03805776","title":"Intermittent Fasting in Dyslipidemia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT03586115","title":"Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Bari","has_results":false},{"nct_id":"NCT04275375","title":"Autonomic Modulation After Spinal Anesthesia With Depth of Anesthesia and Vital Signs.","phase":"","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"National Central University","has_results":false},{"nct_id":"NCT04823702","title":"Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"NGM Biopharmaceuticals, Inc","has_results":false},{"nct_id":"NCT02388620","title":"Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06444204","title":"A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Principia Biopharma, a Sanofi Company","has_results":false},{"nct_id":"NCT05718258","title":"A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT05259085","title":"Study of ALXN2050 in Participants With Hepatic Impairment","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02586194","title":"Pharmacokinetics Study in Patients With Impaired Hepatic Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT02611505","title":"A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT07055412","title":"Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Neurodawn Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05607173","title":"A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT05126329","title":"Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04136444","title":"A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":true},{"nct_id":"NCT04473664","title":"A Study of Quizartinib Pharmacokinetics in Participants With Moderate Hepatic Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Daiichi Sankyo","has_results":true},{"nct_id":"NCT05283915","title":"Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Sanofi","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}